Private Advisor Group LLC Acquires New Holdings in Certara, Inc. (NASDAQ:CERT)

Private Advisor Group LLC acquired a new stake in Certara, Inc. (NASDAQ:CERT) in the 4th quarter, HoldingsChannel.com reports. The fund acquired 23,568 shares of the company’s stock, valued at approximately $251,000.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Wasatch Advisors LP raised its stake in Certara by 22.4% during the third quarter. Wasatch Advisors LP now owns 9,015,941 shares of the company’s stock worth $105,577,000 after buying an additional 1,651,076 shares during the last quarter. Geneva Capital Management LLC boosted its holdings in Certara by 0.7% during the third quarter. Geneva Capital Management LLC now owns 5,510,209 shares of the company’s stock worth $64,525,000 after purchasing an additional 37,392 shares during the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in Certara by 40.7% during the third quarter. Massachusetts Financial Services Co. MA now owns 3,901,898 shares of the company’s stock worth $45,691,000 after purchasing an additional 1,128,006 shares during the last quarter. State Street Corp boosted its holdings in Certara by 3.4% during the third quarter. State Street Corp now owns 3,679,699 shares of the company’s stock worth $43,089,000 after purchasing an additional 122,411 shares during the last quarter. Finally, Brown Brothers Harriman & Co. purchased a new position in Certara in the third quarter valued at about $27,292,000. Institutional investors own 73.96% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on CERT shares. Barclays upped their price target on shares of Certara from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Stephens reaffirmed an “overweight” rating and set a $17.00 target price on shares of Certara in a report on Thursday, February 27th. William Blair reaffirmed a “market perform” rating on shares of Certara in a report on Thursday, February 27th. Finally, TD Cowen initiated coverage on shares of Certara in a research report on Thursday, February 27th. They set a “buy” rating and a $16.00 price target for the company. Four investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat, Certara currently has a consensus rating of “Moderate Buy” and an average target price of $15.83.

Certara Trading Down 2.4 %

Shares of NASDAQ CERT opened at $11.62 on Friday. Certara, Inc. has a 1 year low of $9.41 and a 1 year high of $19.87. The stock has a market cap of $1.87 billion, a P/E ratio of -58.10, a price-to-earnings-growth ratio of 9.29 and a beta of 1.60. The firm has a 50-day moving average of $12.54 and a 200 day moving average of $11.63. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.